| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Lion’s Mane mushroom (Hericium erinaceus; “HE”; culinary + medicinal mushroom). Key bioactives include erinacines (notably erinacine A; typically mycelium-derived) and hericenones (often fruiting-body-associated), plus polysaccharides (β-glucans). Primary mechanisms (conceptual rank): Bioavailability / PK relevance: activity depends strongly on extract type (mycelium vs fruiting body; erinacine-standardized vs not). Some erinacines are reported to be BBB-permeable in the literature; human PK is not well-characterized for most commercial products. In-vitro vs oral exposure: many anti-cancer / signaling findings use extract concentrations likely above achievable systemic levels from typical supplements (qualifier: high concentration only unless otherwise demonstrated in vivo). Clinical evidence status: small human trials/pilot RCTs for cognition/early AD/MCI and healthy adults (signals but limited); cancer evidence remains largely preclinical/adjunct-hypothesis. Lion’s Mane Mushroom (Hericium erinaceus) is renowned for its potential health benefits, particularly in areas like neuroprotection, cognitive function, and immune support.-Most commonly cited mechanisms of Lion’s Mane is its ability to stimulate the synthesis of Nerve Growth Factor (NGF) -Specific compounds such as hericenones and erinacines present in the mushroom are thought to be responsible for this effect. -May inhibit NF-κB Pathway -May lower the production of pro-inflammatory cytokines (e.g., TNF-α, IL-6) -Neutralize free radicals, reducing oxidative stress -Lion’s Mane influences gut health and, in turn, the gut-brain axis -Anti-inflammatory responses, antioxidant protection -Mushrooms, including Lion’s Mane (Hericium erinaceus), contain ergosterol—a precursor to vitamin D. When exposed to ultraviolet (UV) light (such as sunlight), ergosterol is converted to vitamin D₂ (ergocalciferol). Lion’s Mane (Hericium erinaceus) — Cancer vs Normal Cell Pathway Map
TSF legend: P: 0–30 min; R: 30 min–3 hr; G: >3 hr AD relevance: Lion’s Mane (Hericium erinaceus; especially erinacine-A–enriched mycelium preparations) is primarily studied as a neurotrophic + neuroprotective dietary intervention with small human trials/pilot RCTs in early AD/MCI and related cognitive outcomes. Primary mechanisms (conceptual rank): Bioavailability / PK relevance: effects depend on standardized preparations (erinacine A content; dosing regimen). Evidence base includes a ~49-week pilot double-blind placebo-controlled study of erinacine-A–enriched mycelium; overall evidence remains limited by sample sizes and product variability. Clinical evidence status: small human trials/pilot RCTs (signals but not definitive; adjunct/early evidence). Lion’s Mane (Hericium erinaceus) — AD/Neurodegeneration Pathway Map
TSF legend: P: 0–30 min; R: 30 min–3 hr; G: >3 hr |
| Source: |
| Type: |
| Glutathione (GSH) is a thiol antioxidant that scavenges reactive oxygen species (ROS), resulting in the formation of oxidized glutathione (GSSG). Decreased amounts of GSH and a decreased GSH/GSSG ratio in tissues are biomarkers of oxidative stress. Glutathione is a powerful antioxidant found in every cell of the body, composed of three amino acids: cysteine, glutamine, and glycine. It plays a crucial role in protecting cells from oxidative stress, detoxifying harmful substances, and supporting the immune system. cancer cells can have elevated levels of glutathione, which may help them survive in the oxidative environment created by the immune response and chemotherapy. This can make cancer cells more resistant to treatment. While glutathione can be obtained from certain foods (like fruits, vegetables, and meats), its absorption from supplements is debated. Some people take N-acetylcysteine (NAC) or other precursors to boost glutathione levels, but the effects on cancer prevention or treatment are still being studied. Depleting glutathione (GSH) to raise reactive oxygen species (ROS) is a strategy that has been explored in cancer research and therapy. Many cancer cells have altered redox states and may rely on GSH to survive. Increasing ROS levels can induce stress in these cells, potentially leading to cell death. Certain drugs and compounds can deplete GSH levels. For example, agents like buthionine sulfoximine (BSO) inhibit the synthesis of GSH, leading to its depletion. Cancer cells tend to exhibit higher levels of intracellular GSH, possibly as an adaptive response to a higher metabolism and thus higher steady-state levels of reactive oxygen species (ROS). "...intracellular glutathione (GSH) exhibits an astounding antioxidant activity in scavenging reactive oxygen species (ROS)..." "Cancer cells have a high level of GSH compared to normal cells." "...cancer cells are affluent with high antioxidant levels, especially with GSH, whose appearance at an elevated concentration of ∼10 mM (10 times less in normal cells) detoxifies the cancer cells." "Therefore, GSH depletion can be assumed to be the key strategy to amplify the oxidative stress in cancer cells, enhancing the destruction of cancer cells by fruitful cancer therapy." The loss of GSH is broadly known to be directly related to the apoptosis progression. |
| 3811- | mushLions, | Hericium erinaceus (Bull.) Pers. Ethanolic Extract with Antioxidant Properties on Scopolamine-Induced Memory Deficits in a Zebrafish Model of Cognitive Impairment |
| - | in-vitro, | NA, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:325 Target#:137 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid